2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride
CAS: 128322-44-1
Ref. 3D-EM58693
10mg | 740,00 € | ||
20mg | 1.160,00 € | ||
50mg | 2.724,00 € | ||
100mg | 5.217,00 € | ||
250mg | 5.797,00 € |
Información del producto
- MCLA
- Mcla, Hydrochloride
- Cypridina Luciferin Methoxy-Analogue
- 2-Methyl-6-(4-Methoxyphenyl)-3,7-Dihydroimidazo[1,2-A]Pyrazin-3(7H)-One Hydrochloride
- 2-Methyl-6-(4-Methoxyphenyl)-3,7-Dihydroimidazo[1,2-A]Pyrazin-3-One Hydrochloride
- 6-(4-Methoxyphenyl)-2-Methyl-3,7-Dihydroimidazo[1,2-A]Pyrazin-3(7H)-One Hydrochloride
- 6-(4-Methoxyphenyl)-2-Methyl-3,7-Dihydroimidazo[1,2-A]Pyrazin-3-One Hydrochloride
- 6-(4-Meophe.)-2-Me-3,7-Dihydroimidazo(A)Pyrazin-3(7H)-On-Hcl
- 6-(4-methoxyphenyl)-2-methylimidazo[1,2-a]pyrazin-3(7H)-one hydrochloride
2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride (ABI) is a potent and selective inhibitor of the enzyme toll-like receptor. The drug has been shown to decrease the metabolic rate in experimental models. ABI has also been used as an analog for other compounds to study their effects on redox potentials and reactive species. It is unclear how ABI inhibits protein synthesis by polymerase chain reaction (PCR). One possible mechanism is that it may inhibit the binding of primers to DNA. ABI also inhibits the production of chemokines which are small proteins that stimulate inflammatory responses. This drug can be used in autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.
Propiedades químicas
Consulta técnica sobre: 3D-EM58693 2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.